nodes	percent_of_prediction	percent_of_DWPC	metapath
Bromfenac—PTGS2—Triamcinolone—psoriatic arthritis	0.332	0.424	CbGbCtD
Bromfenac—PTGS2—Betamethasone—psoriatic arthritis	0.285	0.364	CbGbCtD
Bromfenac—PTGS2—Dexamethasone—psoriatic arthritis	0.166	0.212	CbGbCtD
Bromfenac—Anterior chamber inflammation—Dexamethasone—psoriatic arthritis	0.0283	0.137	CcSEcCtD
Bromfenac—Anterior chamber inflammation—Betamethasone—psoriatic arthritis	0.0283	0.137	CcSEcCtD
Bromfenac—Corneal thinning—Betamethasone—psoriatic arthritis	0.0126	0.061	CcSEcCtD
Bromfenac—Corneal thinning—Dexamethasone—psoriatic arthritis	0.0126	0.061	CcSEcCtD
Bromfenac—Corneal oedema—Betamethasone—psoriatic arthritis	0.00813	0.0394	CcSEcCtD
Bromfenac—Corneal erosion—Dexamethasone—psoriatic arthritis	0.00813	0.0394	CcSEcCtD
Bromfenac—Corneal erosion—Betamethasone—psoriatic arthritis	0.00813	0.0394	CcSEcCtD
Bromfenac—Corneal oedema—Dexamethasone—psoriatic arthritis	0.00813	0.0394	CcSEcCtD
Bromfenac—Ulcerative keratitis—Prednisolone—psoriatic arthritis	0.00808	0.0392	CcSEcCtD
Bromfenac—Sensation of foreign body—Prednisolone—psoriatic arthritis	0.00626	0.0304	CcSEcCtD
Bromfenac—Ulcerative keratitis—Prednisone—psoriatic arthritis	0.00587	0.0285	CcSEcCtD
Bromfenac—Ocular discomfort—Methotrexate—psoriatic arthritis	0.00546	0.0265	CcSEcCtD
Bromfenac—Sensation of foreign body—Dexamethasone—psoriatic arthritis	0.00522	0.0253	CcSEcCtD
Bromfenac—Sensation of foreign body—Betamethasone—psoriatic arthritis	0.00522	0.0253	CcSEcCtD
Bromfenac—Conjunctival hyperaemia—Prednisolone—psoriatic arthritis	0.00464	0.0225	CcSEcCtD
Bromfenac—Conjunctival hyperaemia—Betamethasone—psoriatic arthritis	0.00387	0.0188	CcSEcCtD
Bromfenac—Conjunctival hyperaemia—Dexamethasone—psoriatic arthritis	0.00387	0.0188	CcSEcCtD
Bromfenac—Retinal disorder—Methotrexate—psoriatic arthritis	0.00347	0.0168	CcSEcCtD
Bromfenac—Eye disorder—Auranofin—psoriatic arthritis	0.003	0.0146	CcSEcCtD
Bromfenac—Visual acuity reduced—Dexamethasone—psoriatic arthritis	0.00286	0.0139	CcSEcCtD
Bromfenac—Visual acuity reduced—Betamethasone—psoriatic arthritis	0.00286	0.0139	CcSEcCtD
Bromfenac—Stinging—Prednisolone—psoriatic arthritis	0.00252	0.0122	CcSEcCtD
Bromfenac—Eye irritation—Prednisolone—psoriatic arthritis	0.00239	0.0116	CcSEcCtD
Bromfenac—Stinging—Triamcinolone—psoriatic arthritis	0.00232	0.0112	CcSEcCtD
Bromfenac—Stinging—Dexamethasone—psoriatic arthritis	0.0021	0.0102	CcSEcCtD
Bromfenac—Stinging—Betamethasone—psoriatic arthritis	0.0021	0.0102	CcSEcCtD
Bromfenac—PTGS2—Fluocinonide—Methylprednisolone—psoriatic arthritis	0.00168	0.159	CbGdCrCtD
Bromfenac—PTGS2—Fluocinonide—Betamethasone—psoriatic arthritis	0.00165	0.156	CbGdCrCtD
Bromfenac—PTGS2—Fluocinonide—Dexamethasone—psoriatic arthritis	0.00165	0.156	CbGdCrCtD
Bromfenac—PTGS2—Fluocinonide—Triamcinolone—psoriatic arthritis	0.00161	0.153	CbGdCrCtD
Bromfenac—Eye pain—Betamethasone—psoriatic arthritis	0.00137	0.00664	CcSEcCtD
Bromfenac—Eye pain—Dexamethasone—psoriatic arthritis	0.00137	0.00664	CcSEcCtD
Bromfenac—Asthma—Triamcinolone—psoriatic arthritis	0.00118	0.00571	CcSEcCtD
Bromfenac—PTGS2—Fluticasone Propionate—Methylprednisolone—psoriatic arthritis	0.00101	0.0958	CbGdCrCtD
Bromfenac—PTGS2—Fluticasone Propionate—Dexamethasone—psoriatic arthritis	0.000997	0.0943	CbGdCrCtD
Bromfenac—PTGS2—Fluticasone Propionate—Betamethasone—psoriatic arthritis	0.000997	0.0943	CbGdCrCtD
Bromfenac—Epistaxis—Triamcinolone—psoriatic arthritis	0.00099	0.0048	CcSEcCtD
Bromfenac—PTGS2—Fluticasone Propionate—Triamcinolone—psoriatic arthritis	0.000975	0.0921	CbGdCrCtD
Bromfenac—Eye disorder—Methylprednisolone—psoriatic arthritis	0.000879	0.00426	CcSEcCtD
Bromfenac—Mediastinal disorder—Methylprednisolone—psoriatic arthritis	0.000847	0.00411	CcSEcCtD
Bromfenac—Vision blurred—Prednisolone—psoriatic arthritis	0.000841	0.00408	CcSEcCtD
Bromfenac—Eye disorder—Betamethasone—psoriatic arthritis	0.000799	0.00388	CcSEcCtD
Bromfenac—Eye disorder—Dexamethasone—psoriatic arthritis	0.000799	0.00388	CcSEcCtD
Bromfenac—Asthma—Methotrexate—psoriatic arthritis	0.000777	0.00377	CcSEcCtD
Bromfenac—Cough—Triamcinolone—psoriatic arthritis	0.000716	0.00347	CcSEcCtD
Bromfenac—Eye disorder—Prednisone—psoriatic arthritis	0.000696	0.00338	CcSEcCtD
Bromfenac—Epistaxis—Methotrexate—psoriatic arthritis	0.000654	0.00317	CcSEcCtD
Bromfenac—Pain—Prednisolone—psoriatic arthritis	0.000623	0.00302	CcSEcCtD
Bromfenac—Vision blurred—Prednisone—psoriatic arthritis	0.000611	0.00296	CcSEcCtD
Bromfenac—Eye disorder—Methotrexate—psoriatic arthritis	0.000582	0.00282	CcSEcCtD
Bromfenac—Pain—Triamcinolone—psoriatic arthritis	0.000573	0.00278	CcSEcCtD
Bromfenac—Mediastinal disorder—Methotrexate—psoriatic arthritis	0.000561	0.00272	CcSEcCtD
Bromfenac—Pain—Dexamethasone—psoriatic arthritis	0.000519	0.00252	CcSEcCtD
Bromfenac—Pain—Betamethasone—psoriatic arthritis	0.000519	0.00252	CcSEcCtD
Bromfenac—Vision blurred—Methotrexate—psoriatic arthritis	0.000511	0.00248	CcSEcCtD
Bromfenac—Cough—Methotrexate—psoriatic arthritis	0.000473	0.00229	CcSEcCtD
Bromfenac—Headache—Prednisolone—psoriatic arthritis	0.000456	0.00221	CcSEcCtD
Bromfenac—Headache—Triamcinolone—psoriatic arthritis	0.000419	0.00203	CcSEcCtD
Bromfenac—Headache—Methylprednisolone—psoriatic arthritis	0.000418	0.00203	CcSEcCtD
Bromfenac—Headache—Dexamethasone—psoriatic arthritis	0.000381	0.00185	CcSEcCtD
Bromfenac—Headache—Betamethasone—psoriatic arthritis	0.000381	0.00185	CcSEcCtD
Bromfenac—Pain—Methotrexate—psoriatic arthritis	0.000378	0.00183	CcSEcCtD
Bromfenac—Headache—Prednisone—psoriatic arthritis	0.000331	0.00161	CcSEcCtD
Bromfenac—Headache—Methotrexate—psoriatic arthritis	0.000277	0.00134	CcSEcCtD
